Bionical Revenue and Competitors

Hillsborough, NJ USA

Location

N/A

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • Bionical's estimated annual revenue is currently $52.5M per year.(i)
  • Bionical's estimated revenue per employee is $201,000

Employee Data

  • Bionical has 261 Employees.(i)
  • Bionical grew their employee count by -25% last year.

Bionical's People

NameTitleEmail/Phone
1
Joint CEOReveal Email/Phone
2
Chief Technology OfficerReveal Email/Phone
3
VP, Creative ServicesReveal Email/Phone
4
VP, Business DevelopmentReveal Email/Phone
5
SVP Strategic AccountsReveal Email/Phone
6
VP OperationsReveal Email/Phone
7
Head HealthWareReveal Email/Phone
8
Head Products & Services Development - Bionical DigitalReveal Email/Phone
9
Head InsightsReveal Email/Phone
10
VP Business DevelopmentReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$6.6M3332%N/AN/A
#2
$38M1896%N/AN/A
#3
$6.6M3322%N/AN/A
#4
$4180M152421%$550MN/A
#5
$17.5M8750%N/AN/A
#6
$6.7M125-37%$199.6MN/A
#7
$10.9M5415%N/AN/A
#8
$15.3M7633%N/AN/A
#9
$128.6M64016%N/AN/A
#10
$18.7M9321%N/AN/A
Add Company

What Is Bionical?

Bionical provides high quality clinical, commercial and communications services to pharmaceutical, biotech and public health companies in the global healthcare industry.With a mission to improve health outcomes, Bionical's services accelerate product and treatment development and enhance communication and engagement with healthcare professionals and patients.

keywords:N/A

N/A

Total Funding

261

Number of Employees

$52.5M

Revenue (est)

-25%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Bionical News

2022-03-22 - Ian Fraser appointed as EVP Clinical Development

Bionical Emas is a global Contract Research Organisation (CRO) business which combines clinical development, early access program and clinical...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$79.9M269N/AN/A
#2
$81.4M2748%N/A
#3
$39.6M3172%N/A
#4
$110.4M3270%N/A
#5
$139.1M6187%N/A